Published: 2006-09-25 17:01:44 CEST
ALK-Abelló - Company Announcement
ALK-Abelló, Grazax® approved in Europe
Authorities in 27 European countries have now approved GRAZAX®, ALK-Abelló's
tablet-based vaccine against grass pollen allergy. ALK-Abelló still expects to
launch GRAZAX® on the first European markets by the end of 2006 and ahead of
the 2007 pollen season.